Publications Early Breast Cancer
- « overview publications
- Concomitant docetaxel plus gemcitabine versus sequential docetaxel followed by gemcitabine in anthracycline-pretreated metastatic or locally recurrent inoperable breast cancer patients: a prospective multicentre trial of the Central European Cooperative Oncology Group (CECOG)
Antoaneta Tomova1, Rupert Bartsch, Thomas Brodowicz, Valentina Tzekova, Constanta Timcheva, Christoph Wiltschke, Dany Abi Gerges, Jan Pawlega, Stanislav Spanik, Moshe Inbar and Christoph C. Zielinski
Breast Cancer Research and Treatment Sept. 2009 www.springerlink.com/content/t3g54827262v24t0/
- Feasibility of two dose-dense FEC regimens with growth factor support
for adjuvant therapy in patients with early breast cancer: results
from a randomised CECOG study
Z. Kahán, S. Spanik, M. Wagnerova, T. Skacel, B. Planko, E. Fitzthum, E. Lindner, V. Soldatenkova, C. Zielinski, T. Brodowicz.
Breast Cancer Research and Treatment 2008, Jan. 13
- A randomized, open-label CECOG phase II study of dose-dense FEC 75
vs FEC 90 as adjuvant therapy in early breast cancer patients.
Z. Kahán, S. Spanik, M. Wagnerova, T. Skacel, B. Planko, E. Fitzthum, E. Lindner, V. Soldatenkova, C. Zielinski, T. Brodowicz.
ECCO 2007 (#2095)
For publications of the results of the Consensus Conferenences
see Consensus Statements